Track the latest Actuate Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Actuate Therapeutics stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Aug 16, 2024 | TODD THOMSONKairos SPV Fund LLCKairos Venture Opportunities I LPKairos Venture Partners II LPKairosActuate SPV LP | DIRECTOR | 2.59M | $6.63 | $5.28 | SELL-OPTIONS | ∞ | 1.18M | Aug 14 | View |
Aug 14, 2024 | Bios Equity COF LPBios Clinical Opportunity Fund LPBP Directors LP | DIRECTOR | 9.89M | $8.40 | $3.98M | BUY | ∞ | 131.25K | Aug 14 | View |
Aug 14, 2024 | GL Aaron FletcherBIOS Capital Management LPBIOS Advisors GP LLCBIOS Fund III LPBIOS Fund III QP LPBIOS Fund III NT LPBIOS Actuate CoInvest I LPBIOS Actuate CoInvest II LPBios Actuate CoInvest III LPBIOS Equity Partners III LP | DIRECTOR | 9.89M | $8.40 | $3.98M | BUY | ∞ | 131.25K | Aug 14 | View |
Aug 14, 2024 | Leslie KreisCavu Advisors LLCCavu Management LPBIOS Fund I LPBIOS Fund I QP LPBios Equity Partners LPBIOS Fund II LPBIOS Fund II NT LPBIOS Fund II QP LPBios Equity Partners II LP | DIRECTOR | 9.89M | $8.40 | $3.98M | BUY | ∞ | 131.25K | Aug 14 | View |
Browse insider trades on all stocks.